How to Read a Certificate of Analysis (COA) for Peptides

Written by NorthPeptide Research Team

For laboratory and research use only. Not for human consumption.

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is the quality control document that accompanies a research-grade chemical, providing analytical data that verifies the identity, purity, and physical characteristics of a specific batch. In the peptide research industry, the COA is the single most important document a researcher should review before incorporating any peptide into an experimental protocol. It is the objective record of what is actually in the vial — not what the label says, but what the instruments measured.

Every legitimate peptide supplier issues COAs for each production lot. These documents typically contain results from multiple analytical techniques, including high-performance liquid chromatography (HPLC), mass spectrometry (MS), and sometimes additional tests such as amino acid analysis, endotoxin screening, and counterion quantification. Together, these data points form a composite picture of peptide quality that allows researchers to make informed decisions about whether a given lot meets the requirements of their experimental design.

The importance of COA literacy cannot be overstated. A 2019 study published in Science found that many commercially available research reagents — including peptides — failed to meet their stated specifications, with some containing significant impurities or incorrect sequences. The authors emphasized that “end-user verification of reagent quality is essential for reproducible research” and that analytical certificates should be critically evaluated rather than accepted at face value (PMID: 31249141).

This guide explains each section of a typical peptide COA, what the numbers mean, how to interpret them in the context of your research, and how to identify warning signs that suggest a COA may be unreliable or that a peptide may not meet research-grade standards. For broader context on quality tiers, see our guide on research-grade vs. pharmaceutical-grade peptides.

HPLC Purity Analysis

High-performance liquid chromatography is the primary analytical method used to determine peptide purity, and the HPLC purity value is typically the most prominent number on any COA. Understanding what this number represents — and what it does not — is fundamental to evaluating peptide quality.

How HPLC Works for Peptides

In reverse-phase HPLC (RP-HPLC), the most common technique for peptide analysis, the sample is dissolved and injected into a column packed with hydrophobic stationary phase material (typically C18-bonded silica). A gradient of increasingly organic mobile phase (usually acetonitrile with trifluoroacetic acid) is pumped through the column. Peptides and impurities separate based on their hydrophobicity — more hydrophilic components elute first, while more hydrophobic species are retained longer on the column.

As each component elutes from the column, it passes through a UV detector (typically set at 214 nm or 220 nm, wavelengths where the peptide bond absorbs strongly). The detector generates a chromatogram — a graph of UV absorbance versus retention time — where each separated component appears as a peak. The area under each peak is proportional to the amount of that component in the sample.

Reading the Chromatogram

A well-resolved HPLC chromatogram for a high-purity peptide should show one dominant peak (the target peptide) with minimal additional peaks. Key features to evaluate include:

• Main peak — The largest peak corresponds to the target peptide. Its retention time should be consistent with the expected hydrophobicity of the sequence. For most peptides of 5–50 amino acids, the main peak typically elutes between 10 and 30 minutes depending on gradient conditions.
• Peak shape — A symmetrical, Gaussian peak shape indicates a single, well-behaved component. Fronting (a leading edge) or tailing (a trailing edge) can suggest column overloading, secondary interactions, or the presence of closely related impurities that are not fully resolved from the main peak.
• Impurity peaks — Smaller peaks flanking the main peak represent impurities. These may include deletion sequences (peptides missing one or more amino acids from the target sequence), truncated sequences, oxidized forms, deamidated forms, or incompletely deprotected synthesis intermediates. The number and size of impurity peaks directly reflect synthesis quality and purification effectiveness.
• Baseline — A flat, stable baseline indicates clean separation and good instrument performance. A rising baseline, excessive noise, or broad humps suggest problems with the analysis or the presence of polymeric or aggregated material that does not elute as discrete peaks.
• Solvent front — The initial disturbance near the injection point (typically 1–3 minutes) is the solvent front, where unretained components such as salts, TFA, and very hydrophilic impurities elute. This region is excluded from purity calculations.

Understanding Purity Percentage

The purity value reported on a COA is calculated as the area percentage of the main peak relative to all detected peaks in the chromatogram. A purity of 98% means the main peak accounts for 98% of the total peak area, with all impurity peaks collectively accounting for the remaining 2%.

For most research applications, a purity of >95% is considered acceptable, while >98% is regarded as high purity. Certain sensitive applications — particularly those involving cell culture, in vivo animal studies, or biophysical characterization — may require purities of >99%. The appropriate purity threshold depends entirely on the experimental context, as discussed in analytical chemistry literature on peptide quality control (PMC6723142).

Purity Level	Typical Use	Considerations
>99%	In vivo studies, cell-based assays, structural biology	Minimal impurity interference; highest confidence in dose-response data
95–98%	Binding assays, enzyme kinetics, general screening	Acceptable for most biochemical research; impurities unlikely to affect outcomes significantly
90–95%	Preliminary screening, antibody production, method development	May contain meaningful impurity levels; confirm impurity identity if results are critical
<90%	Crude material, not suitable for most research	High impurity burden; results may be confounded by co-eluting contaminants

Limitations of HPLC Purity

HPLC purity is an extremely useful measure, but it has important limitations. It does not detect impurities that do not absorb UV light at the detection wavelength. It does not detect co-eluting impurities (species with identical retention times to the target peptide). It cannot distinguish between different types of impurities, and it does not provide structural information about the main peak — a peptide with the wrong sequence but similar hydrophobicity could produce an identical retention time. This is why mass spectrometry is used alongside HPLC to confirm molecular identity.

Mass Spectrometry Data

While HPLC tells you how pure the sample is, mass spectrometry tells you what the sample is. Mass spectrometry (MS) measures the molecular weight of the peptide, providing direct confirmation that the synthesis produced the intended sequence. This is the identity test — the analytical equivalent of checking a fingerprint.

How Peptide Mass Spectrometry Works

The two most common ionization techniques for peptide mass spectrometry are electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). Both techniques convert the peptide into gas-phase ions, which are then separated by their mass-to-charge ratio (m/z) and detected.

• ESI-MS — Produces multiply charged ions, generating a series of peaks at different charge states (e.g., [M+2H]²⁺, [M+3H]³⁺). The molecular weight is calculated by deconvolution of these charge states. ESI is well-suited for peptides of all sizes and is often coupled directly with HPLC (LC-MS) for simultaneous separation and identification.
• MALDI-TOF — Produces predominantly singly charged ions ([M+H]⁺), giving a simpler spectrum with a single major peak at the molecular weight plus one proton mass. MALDI is faster for routine molecular weight confirmation and is commonly used in peptide synthesis quality control.

Interpreting the Mass Spectrum

The COA will report the observed molecular weight alongside the expected (theoretical) molecular weight calculated from the peptide sequence. Key points to check:

• Expected vs. observed molecular weight — The observed mass should match the theoretical molecular weight within the instrument’s accuracy. For MALDI-TOF, agreement within ±1 Da (dalton) for peptides under 3,000 Da is typical. For ESI, agreement within ±0.5 Da is expected. A discrepancy greater than these tolerances suggests the wrong peptide, a modification, or a synthesis error.
• Common mass shifts — Certain mass shifts indicate specific problems: +16 Da suggests oxidation (typically methionine), +1 Da may indicate deamidation (asparagine or glutamine), −18 Da suggests aspartimide formation, and differences corresponding to amino acid residue masses suggest deletion or insertion errors.
• Adduct peaks — Peaks at [M+Na]⁺ (observed mass + 22 Da) or [M+K]⁺ (observed mass + 38 Da) are sodium and potassium adducts, which are common and not concerning. They represent the same peptide ionized with different cation attachments.
• Isotope pattern — High-resolution instruments will show the isotope distribution pattern, which should match the predicted pattern for the molecular formula. This provides additional confirmation of identity beyond the monoisotopic mass alone.

Molecular Weight Calculation

For researchers who want to verify the expected molecular weight independently, it is calculated from the sum of amino acid residue masses plus the mass of water (18.015 Da) for the terminal groups. Standard amino acid monoisotopic residue masses are well-documented in proteomics databases and mass spectrometry resources (PMID: 16038019). Any modifications (acetylation, amidation, disulfide bonds) must be accounted for in the calculation.

Amino Acid Analysis

Amino acid analysis (AAA) is a complementary technique that hydrolyzes the peptide into its constituent amino acids and quantifies each one. While not present on every COA, AAA provides valuable information that HPLC and MS cannot.

The peptide is hydrolyzed in 6 M HCl at 110°C for 18–24 hours, breaking all peptide bonds. The resulting free amino acids are then derivatized and quantified by chromatography. The measured amino acid ratios are compared against the theoretical ratios expected from the sequence. Agreement within ±10% for each amino acid is considered acceptable.

AAA has specific limitations: tryptophan is destroyed during acid hydrolysis, asparagine and glutamine are converted to aspartic acid and glutamic acid respectively (and thus cannot be distinguished), and cysteine may be partially destroyed unless performic acid oxidation is performed prior to hydrolysis. Despite these limitations, AAA remains the gold standard for peptide content determination — the actual amount of peptide (as opposed to counterions, water, and TFA) present per milligram of powder (PMC7324166).

Peptide Content vs. Purity

This is a critical distinction that many researchers overlook. HPLC purity measures what percentage of the peptide-related material is the target sequence. Peptide content measures what percentage of the total powder mass is actually peptide. A peptide can be 99% pure by HPLC but have a peptide content of only 60–80%, because the remaining mass consists of counterions (TFA salts), residual water, and residual solvents.

For dosing accuracy in research protocols, peptide content is essential. If a vial contains 10 mg of powder with 70% peptide content, the actual peptide mass is 7 mg. Failing to account for this can introduce systematic errors into dose-response experiments.

Endotoxin Testing (LAL Assay)

Endotoxin testing is particularly important for peptides intended for cell culture or in vivo research. Endotoxins — lipopolysaccharides (LPS) from the outer membrane of Gram-negative bacteria — are potent activators of the innate immune system and can confound biological assays at extremely low concentrations.

The Limulus Amebocyte Lysate (LAL) assay is the standard method for endotoxin detection, based on the clotting reaction of horseshoe crab blood cells in the presence of endotoxin. Results are reported in Endotoxin Units per milligram (EU/mg). For research-grade peptides:

Application	Acceptable Endotoxin Level
Cell culture studies	<1.0 EU/mg
In vivo animal studies	<0.5 EU/mg (often <0.25 EU/mg)
General biochemical assays	<5.0 EU/mg (usually sufficient)

If a COA does not include endotoxin testing and you plan to use the peptide in biological systems, you should either request endotoxin data from the supplier or perform your own LAL testing before use. Endotoxin contamination is one of the most common confounders in peptide-based biological research (PMC5751736).

TFA Content and Counterion Information

Trifluoroacetic acid (TFA) is used extensively in solid-phase peptide synthesis (SPPS) — both as a cleavage reagent and as an ion-pairing agent in HPLC purification. As a result, most synthetic peptides are isolated as TFA salts, with TFA molecules associated with basic amino acid residues (lysine, arginine, histidine) and the N-terminus.

TFA content can represent a substantial fraction of the total powder mass — sometimes 10–30% by weight, depending on the number of basic residues in the sequence. This directly affects peptide content calculations and can be relevant for biological applications, as TFA at high concentrations can be cytotoxic in cell culture.

Some suppliers offer acetate salt or hydrochloride salt forms as alternatives, produced by counterion exchange after synthesis. If TFA content is a concern for your research, look for COAs that specify the counterion form or that report TFA content by ion chromatography or fluorine NMR. For more on peptide synthesis and the role of TFA, see our guide on how peptides are made via SPPS.

Appearance and Solubility Data

The COA will typically include a physical description of the peptide — its appearance (e.g., “white lyophilized powder,” “off-white fluffy powder”) and sometimes solubility information. While these may seem like minor details, they serve important quality control functions.

• Color — Most synthetic peptides should be white to off-white. A yellow or brown color may indicate oxidation, degradation, or contamination. Peptides containing tryptophan may have a slightly yellowish tint, which is normal.
• Form — Lyophilized (freeze-dried) peptides appear as a fluffy, porous powder or cake. A glassy, collapsed, or sticky appearance may indicate inadequate lyophilization or hygroscopic behavior.
• Solubility — If reported, solubility data helps researchers prepare stock solutions. Hydrophilic peptides typically dissolve readily in water or aqueous buffers. Hydrophobic peptides may require initial dissolution in a small volume of DMSO, acetic acid, or acetonitrile before dilution into aqueous buffer. The COA should specify the solvent system and concentration tested.

Batch and Lot Numbers

Every COA should bear a unique batch or lot number that links the analytical data to a specific production run. This traceability is essential for several reasons:

• Reproducibility — If you obtain excellent results with a particular lot, you can request the same lot for follow-up experiments, or at minimum confirm that a new lot has comparable analytical specifications.
• Troubleshooting — If results suddenly change when using a new batch, the lot number allows you to compare COAs and identify whether the peptide quality has changed.
• Regulatory compliance — Institutional review boards and journal editors increasingly require documentation of reagent lot numbers for published research, as part of broader efforts to improve reproducibility.
• Recall or advisory — In the rare event that a quality issue is identified after distribution, the lot number enables targeted communication and replacement.

A COA without a lot number, or with a lot number that does not change between orders of different sizes or dates, should be viewed with skepticism. Each production run should generate unique analytical data tied to a unique identifier.

Red Flags: Identifying a Questionable COA

Not all COAs are created equal. Some suppliers issue generic or fabricated certificates that do not reflect actual testing of the specific lot being sold. Learning to distinguish reliable COAs from questionable ones is an essential skill for any researcher purchasing peptides. The following red flags should prompt further investigation or a change in supplier.

Signs of a Potentially Unreliable COA

• No chromatogram included — A purity number without the supporting HPLC chromatogram cannot be independently evaluated. Reputable suppliers include the actual chromatogram, not just the calculated purity value.
• No mass spectrum included — Similarly, a molecular weight value without the supporting mass spectrum provides no verification of identity. The raw spectral data should be available.
• Identical COAs across lots — If two different lot numbers have identical analytical data (same retention time to the decimal, same peak areas, same mass spectrum), the COA is likely a template that has not been updated with real analytical data for each batch.
• Missing instrument parameters — A reliable COA should specify the HPLC column type, mobile phase composition, gradient conditions, flow rate, and detection wavelength. Without these, the analysis cannot be reproduced or evaluated.
• Suspiciously round numbers — A purity reported as exactly “99.00%” or a molecular weight reported with no decimal places may indicate fabricated data rather than actual instrument output, which inherently produces values with variable precision.
• No date of analysis — The analysis date, in conjunction with the production date, tells you how fresh the data is. A COA without dates cannot be assessed for relevance to the material you received.
• No analyst signature or laboratory identification — Quality control documentation should identify who performed the analysis and which laboratory produced it. Anonymous COAs with no institutional attribution are a concern.
• Purity claims that exceed method capability — Claims of 99.99% purity by standard RP-HPLC should be viewed skeptically, as the practical resolution limit of standard HPLC methods for peptides typically does not support claims beyond approximately 99.5% with confidence.

Signs of a Reliable COA

• Complete chromatographic data — Full HPLC chromatogram with labeled axes, identified main peak, and visible impurity peaks (even if small).
• Full mass spectral data — Mass spectrum showing the expected molecular ion and any charge states, with clear labeling of observed vs. expected masses.
• Detailed method parameters — Column specifications, gradient conditions, flow rate, detection wavelength, injection volume, and instrument model.
• Unique lot-specific data — Analytical values that differ slightly between lots (as would be expected from independent analyses of different production batches).
• Multiple analytical techniques — COAs that include HPLC, MS, and additional data (AAA, endotoxin, water content) demonstrate a more thorough quality control process.
• Third-party testing — Some suppliers use independent analytical laboratories for quality control, which provides an additional layer of verification.

How NorthPeptide COAs Work

At NorthPeptide, every lot of peptide undergoes independent analytical testing before release. Our COAs include:

• RP-HPLC analysis — Full chromatogram with method parameters, using C18 columns and acetonitrile/TFA gradients at 214 nm detection. Purity is calculated by area normalization with a minimum threshold of 98% for release.
• Mass spectrometry — ESI-MS or MALDI-TOF confirmation of molecular weight, with the full spectrum provided alongside the expected and observed mass values.
• Appearance and solubility — Physical description of the lyophilized material.
• Batch-specific lot numbers — Each production batch receives a unique identifier that links to all associated analytical data.
• Endotoxin testing — LAL assay results are available for peptides designated for biological research applications.

All COAs are available for download from the product pages on our website, and we are happy to provide additional analytical data upon request. We believe that transparency in quality control is not optional — it is the foundation of trustworthy research supply. For guidance on safe handling practices once you have verified your peptide quality, see our peptide research safety best practices guide.

Practical Checklist: Evaluating a Peptide COA

Before using any peptide in your research, work through this checklist to ensure the COA meets minimum quality standards:

Check	What to Look For	Acceptable Standard
HPLC purity	Area percentage of main peak	>95% for screening; >98% for quantitative work
Chromatogram provided	Actual HPLC trace with labeled peaks	Yes — not just a number
Mass spectrum provided	MS data showing observed molecular weight	Yes — within ±1 Da of expected MW
Lot number	Unique batch identifier	Present and lot-specific
Date of analysis	When the testing was performed	Recent and clearly stated
Method parameters	Column, gradient, flow rate, wavelength	Sufficiently detailed to evaluate or reproduce
Endotoxin (if applicable)	LAL result in EU/mg	<1.0 EU/mg for biological applications
Counterion/TFA	Salt form or TFA content	Specified — relevant for dosing accuracy

The Role of COAs in Research Reproducibility

The broader scientific community has increasingly recognized that reagent quality is a major contributor to the reproducibility crisis in biomedical research. A landmark analysis published in PLOS Biology estimated that irreproducible preclinical research costs approximately $28 billion annually in the United States alone, with reagent quality identified as one of the key contributing factors (PMC4461318).

For peptide research specifically, the absence of rigorous quality verification can lead to false-positive results (biological activity from impurities rather than the target peptide), false-negative results (insufficient active peptide due to low peptide content), dose-response artifacts, and wasted time and resources pursuing leads based on contaminated material.

The National Institutes of Health has issued guidance emphasizing the importance of authenticating key biological and chemical reagents, including synthetic peptides, and recommends that researchers document supplier, lot number, and quality control data for all reagents used in funded research (PMID: 24482835).

By taking the time to read and critically evaluate every COA, researchers contribute not only to the quality of their own work but to the integrity of the broader scientific literature.

---

Summary of Key References

Study	Year	Type	Focus	Reference
Bhatt et al.	2019	Analysis	Research reagent quality and reproducibility	PMID: 31249141
D’Hondt et al.	2014	Review	Quality control in peptide manufacturing	PMC6723142
Kish-Trier & Richardson	2014	Review	Quantitative amino acid analysis methods	PMC7324166
Schwarz et al.	2017	Review	Endotoxin contamination in biological research	PMC5751736
Freedman et al.	2015	Analysis	Economic cost of irreproducible research	PMC4461318
Kuster et al.	2005	Reference	Mass spectrometry nomenclature and amino acid masses	PMID: 16038019
Collins & Bhatt (NIH)	2014	Policy	NIH guidance on research reagent authentication	PMID: 24482835

---

For laboratory and research use only. Not for human consumption.

This article is a summary of published, peer-reviewed research and is intended for educational purposes. It does not constitute medical advice, and the compounds discussed are not approved drugs for any clinical indication discussed above.

All NorthPeptide products are sold exclusively for legitimate scientific investigation by qualified researchers. If you are considering any research protocol, consult institutional review guidelines and all applicable regulations.